Premium
Letter: double‐dose intensification—a quick way to reverse antibody formation and loss of response in patients treated with adalimumab. Authors reply
Author(s) -
Ungar Bella,
Ben Horin Shomron,
Roblin Xavier
Publication year - 2019
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.15139
Subject(s) - medicine , adalimumab , tumor necrosis factor alpha